SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study

被引:72
作者
Parker, Gordon [1 ]
Tully, Lucy
Olley, Amanda
Hadzi-Pavlovic, Dusan
机构
[1] Prince Wales Hosp, Black Dog Inst, Sydney, NSW 2031, Australia
[2] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia
关键词
bipolar disorder; mood stabilizer; SSRIs; hypomania; depression;
D O I
10.1016/j.jad.2006.01.024
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We have previously observed that prescription of some antidepressant class drugs (particularly the SSRIs) is associated with attenuation of the number, duration and severity of both high and low mood states in those with Bipolar II Disorder. We examined whether SSRIs are a mood stabilizer for Bipolar II Disorder. Method: We report a randomized, double-blind, placebo-controlled cross-over study lasting 9 months in a sample of 10 patients who had not had previous treatment with any antidepressant, antipsychotic or mood stabilizer drug. Results: Treatment with the SSRI led to a significant reduction in depression severity, percentage of days depressed or high, and percentage of days impaired, when compared with placebo. There was no indication that the SSRI led to a worsening of illness course. Limitations: Given the small sample size and a weighting to those with a rapid cycling condition, replication with a larger and more heterogeneous sample of those with Bipolar Disorder is required. Conclusions: This proof of concept study finds preliminary support for the potential utility of SSRIs in managing Bipolar H Disorder, with clear improvements in depression and impairment and some suggested benefit for hypomania. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 13 条
[1]   Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders [J].
Akiskal, HS ;
Bourgeois, ML ;
Angst, J ;
Post, R ;
Möller, HJ ;
Hirschfeld, R .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 59 :S5-S30
[2]   Antidepressant monotherapy for bipolar type II major depression [J].
Amsterdam, JD ;
Brunswick, DJ .
BIPOLAR DISORDERS, 2003, 5 (06) :388-395
[3]   Toward a re-definition of subthreshold bipolarity:: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania [J].
Angst, J ;
Gamma, A ;
Benazzi, F ;
Ajdacic, V ;
Eich, D ;
Rössler, W .
JOURNAL OF AFFECTIVE DISORDERS, 2003, 73 (1-2) :133-146
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]   Is 4 days the minimum duration of hypomania in bipolar II disorder? [J].
Benazzi, F .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (01) :32-34
[6]  
COHEN J, 1988, STAT POWER ANLA BEH
[7]  
Cortina J.M., 2000, EFFECT SIZE ANOVA DE
[8]   Antidepressants for bipolar depression: A systematic review of randomized, controlled trials [J].
Gijsman, HJ ;
Geddes, JR ;
Rendell, JM ;
Nolen, WA ;
Goodwin, GM .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (09) :1537-1547
[9]   Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology [J].
Goodwin, GM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (02) :149-173
[10]   Bipolar II Disorder: An Overview of Recent Developments [J].
Hadjipavlou, George ;
Mok, Hiram ;
Yatham, Lakshmi N. .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (12) :802-812